Holocene Advisors’s Privia Health PRVA Stock Holding History

Holocene Advisors’s Portfolio PRVA Stock Details PRVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$668K	Sell	25,948 -48,443	-65%	-$1.12M	﹤0.01%	718
2026 Q1	$1.53M	Buy	74,391 +62,981	+552%	+$1.42M	﹤0.01%	615
2025 Q4	$271K	Sell	11,410 -14,618	-56%	-$356K	﹤0.01%	706
2025 Q3	$648K	Buy	+26,028	New	+$560K	﹤0.01%	665
2024 Q4	–	Sell	-23,799	Closed	-$433K	–	856
2024 Q3	$433K	Sell	23,799 -79,819	-77%	-$1.52M	﹤0.01%	673
2024 Q2	$1.8M	Sell	103,618 -7,128	-6%	-$126K	0.01%	540
2024 Q1	$2.17M	Buy	110,746 +30,143	+37%	+$637K	0.01%	567
2023 Q4	$1.86M	Hold	80,603	–	–	0.01%	542
2023 Q3	$1.85M	Buy	+80,603	New	+$2.05M	0.01%	574
2022 Q2	–	Sell	-78,410	Closed	-$2.1M	–	965
2022 Q1	$2.1M	Buy	78,410 +34,760	+80%	+$821K	0.01%	497
2021 Q4	$1.13M	Buy	43,650 +23,297	+114%	+$581K	0.01%	659
2021 Q3	$480K	Buy	+20,353	New	+$711K	﹤0.01%	749

Other funds holding PRVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Holocene Advisors's PRVA Position: Q2 2026 in Review

Holocene Advisors reduced its Privia Health (PRVA) stake by 65% in Q2 2026, selling an estimated $1.12M and leaving 25,948 shares worth $668K. The position accounts for ﹤0.01% of the portfolio, ranked #718.

Holocene Advisors first reported a position in PRVA in Q3 2021 and has held it in 12 quarters since. The position peaked at $2.17M in Q1 2024. 302 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

Holocene Advisors held 25,948 shares of Privia Health worth $668K as of Q2 2026.
Holocene Advisors sold 48,443 Privia Health shares in Q2 2026, an estimated $1.12M.
Privia Health made up ﹤0.01% of Holocene Advisors's portfolio in Q2 2026, its #718 holding.
Holocene Advisors first reported a position in Privia Health in Q3 2021 and has held it in 12 quarters since.
Holocene Advisors's Privia Health position peaked at $2.17M in Q1 2024.
302 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on Holocene Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.